News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
573,452 Results
Type
Article (49107)
Company Profile (124)
Press Release (524210)
Multimedia
Podcasts (142)
Webinars (19)
Section
Business (151293)
Career Advice (2476)
Deals (29010)
Drug Delivery (141)
Drug Development (70754)
Employer Resources (162)
FDA (16184)
Job Trends (12531)
News (274724)
Policy (30536)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2448)
Academic (1)
Accelerated approval (34)
Adcomms (36)
Allergies (133)
Alliances (38126)
ALS (163)
Alzheimer's disease (1708)
Antibody-drug conjugate (ADC) (315)
Approvals (16335)
Artificial intelligence (492)
Autoimmune disease (153)
Automation (33)
Bankruptcy (317)
Best Places to Work (9616)
BIOSECURE Act (23)
Biosimilars (191)
Biotechnology (75)
Bladder cancer (158)
Brain cancer (54)
Breast cancer (594)
Cancer (4583)
Cardiovascular disease (410)
Career advice (2095)
Career pathing (38)
CAR-T (265)
CDC (59)
Celiac Disease (1)
Cell therapy (729)
Cervical cancer (35)
Clinical research (60424)
Collaboration (1491)
Company closure (4)
Compensation (1148)
Complete response letters (72)
COVID-19 (2757)
CRISPR (87)
C-suite (764)
Cystic fibrosis (142)
Data (5830)
Decentralized trials (2)
Denatured (33)
Depression (146)
Diabetes (480)
Diagnostics (5646)
Digital health (34)
Diversity (7)
Diversity, equity & inclusion (43)
Drug discovery (220)
Drug pricing (221)
Drug shortages (33)
Duchenne muscular dystrophy (236)
Earnings (63821)
Editorial (65)
Employer branding (20)
Employer resources (144)
Events (84655)
Executive appointments (893)
FDA (19248)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (21)
Funding (1283)
Gene editing (195)
Generative AI (42)
Gene therapy (601)
GLP-1 (1066)
Government (4298)
Grass and pollen (8)
Guidances (378)
Healthcare (15498)
HIV (57)
Huntington's disease (49)
IgA nephropathy (84)
Immunology and inflammation (285)
Immuno-oncology (56)
Indications (94)
Infectious disease (3014)
Inflammatory bowel disease (185)
Inflation Reduction Act (14)
Influenza (106)
Intellectual property (237)
Interviews (471)
IPO (14446)
IRA (57)
Job creations (3211)
Job search strategy (1710)
JPM (66)
Kidney cancer (16)
Labor market (81)
Layoffs (617)
Leadership (39)
Legal (7154)
Liver cancer (92)
Longevity (12)
Lung cancer (605)
Lymphoma (355)
Machine learning (40)
Management (55)
Manufacturing (740)
MASH (167)
Medical device (11845)
Medtech (11890)
Mergers & acquisitions (15577)
Metabolic disorders (1312)
Multiple sclerosis (152)
NASH (22)
Neurodegenerative disease (319)
Neuropsychiatric disorders (98)
Neuroscience (2915)
Neurotech (1)
NextGen: Class of 2026 (5298)
Non-profit (3346)
Now hiring (30)
Obesity (659)
Opinion (285)
Ovarian cancer (158)
Pain (191)
Pancreatic cancer (220)
Parkinson's disease (276)
Partnered (29)
Patents (481)
Patient recruitment (447)
Peanut (53)
People (45677)
Pharmaceutical (34)
Pharmacy benefit managers (32)
Phase 1 (18289)
Phase 2 (26240)
Phase 3 (21169)
Pipeline (4884)
Policy (332)
Postmarket research (2266)
Preclinical (7629)
Press Release (59)
Prostate cancer (238)
Psychedelics (54)
Radiopharmaceuticals (246)
Rare diseases (873)
Real estate (4442)
Recruiting (65)
Regulatory (23541)
Reports (40)
Research institute (2219)
Resumes & cover letters (407)
Rett syndrome (27)
RNA editing (16)
RSV (73)
Schizophrenia (153)
Series A (218)
Series B (173)
Service/supplier (8)
Sickle cell disease (97)
Special edition (25)
Spinal muscular atrophy (143)
Sponsored (46)
Startups (2899)
State (1)
Stomach cancer (20)
Supply chain (105)
Tariffs (101)
The Weekly (108)
Vaccines (1086)
Venture capital (94)
Weight loss (460)
Women's health (75)
Worklife (22)
Date
Last 7 days (552)
Last 30 days (1892)
Last 365 days (28527)
2026 (2675)
2025 (28925)
2024 (32187)
2023 (36038)
2022 (46294)
2021 (49794)
2020 (46882)
2019 (37967)
2018 (28697)
2017 (28763)
2016 (26900)
2015 (29424)
2014 (22877)
2013 (18794)
2012 (20033)
2011 (20450)
2010 (18409)
Location
Africa (708)
Alabama (71)
Alaska (6)
Arizona (232)
Arkansas (10)
Asia (33701)
Australia (5927)
California (10466)
Canada (2635)
China (946)
Colorado (405)
Connecticut (460)
Delaware (317)
Europe (81765)
Florida (1582)
Georgia (323)
Hawaii (4)
Idaho (40)
Illinois (746)
India (51)
Indiana (421)
Iowa (22)
Japan (400)
Kansas (109)
Kentucky (26)
Louisiana (19)
Maine (73)
Maryland (1296)
Massachusetts (7530)
Michigan (271)
Minnesota (583)
Mississippi (5)
Missouri (116)
Montana (17)
Nebraska (25)
Nevada (110)
New Hampshire (61)
New Jersey (2830)
New Mexico (18)
New York (2725)
North Carolina (1363)
North Dakota (7)
Northern California (5184)
Ohio (284)
Oklahoma (16)
Oregon (36)
Pennsylvania (2017)
Puerto Rico (17)
Rhode Island (34)
South America (1074)
South Carolina (63)
South Dakota (1)
Southern California (4046)
Tennessee (150)
Texas (1567)
United States (36675)
Utah (262)
Virginia (242)
Washington D.C. (74)
Washington State (845)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
573,452 Results for "nature s toolbox".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nature Communications reports promising effect of Idorsia’s lucerastat on kidney function in Fabry disease
January 12, 2026
·
11 min read
Press Releases
Tubulis Unveils Alco5 Conjugation Platform’s Ability to Expand ADC Payload Scope in Nature Communications
January 21, 2026
·
3 min read
Press Releases
Quanterix Announces Landmark Nature Study Redefining Alzheimer’s Disease Neuropathology Prevalence
December 23, 2025
·
4 min read
Press Releases
Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Nature’s Signal Transduction and Targeted Therapy
November 25, 2025
·
11 min read
Career Advice
Manager’s Toolbox: How to Have Difficult Conversations
Having difficult conversations with the right mindset can build trust and further develop your relationship with your team.
September 4, 2024
·
6 min read
·
Bruce Wu
Press Releases
New Data Underscoring Ability of Leapfrog Bio’s OncoSLX Platform to Identify Drug Retargeting Opportunities for Treating Cancer Published in Nature Portfolio Journal
January 12, 2026
·
4 min read
Press Releases
Nucleai Enables Spatial Biology Research in Nature Communications Study on Lung Cancer Treatment Response
February 4, 2026
·
3 min read
Career Advice
Manager’s Toolbox: Exploring Empathy, Intellectual Curiosity, and Vulnerability
Whether they’re newly minted managers or C-suite executives, effective managers often lead with empathy, intellectual curiosity and vulnerability.
August 6, 2024
·
5 min read
·
Bruce Wu
Press Releases
Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth’s Novel AI-Powered Breast Cancer Detection Workflow
November 18, 2025
·
9 min read
Press Releases
Genyro Signs Exclusive License for “Sidewinder,” a Breakthrough DNA Construction Technology Featured in Nature
January 27, 2026
·
5 min read
1 of 57,346
Next
